Literature DB >> 33447228

Understanding and Treating HER Better.

Marija Balic1.   

Abstract

Year:  2020        PMID： 33447228      PMCID： PMC7768110          DOI： 10.1159/000512415

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN： 1661-3791            Impact factor:   2.860


× No keyword cloud information.
  1 in total

1.  Safety and Clinical Evaluation of Dual Inhibition with Pertuzumab and Trastuzumab Biosimilar SB3 in HER2-Positive Breast Cancer Patients.

Authors:  Christoph Suppan; Daniel Steiner; Eva Valentina Klocker; Florian Posch; Elisabeth Henzinger; Hannah Deborah Müller; Herbert Stöger; Nadia Dandachi; Marija Balic
Journal:  Breast Care (Basel)       Date:  2021-02-10       Impact factor: 2.860
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.